Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lokich

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy Reports|March 1, 1975
Phase I. evaluation of cyclocytidine (NSC-145668)J J Lokich, P L Chawla, N Jaffe, et al.
American Journal of Surgery|April 1, 1983
Management of malignant ascites with peritoneovenous shuntingR B Reinhold, J J Lokich, J Tomashefski, et al.
Journal of Surgical Oncology|January 1, 1979
Pseudo-chondrosarcoma: solitary osseous metastases from atypical bronchogenic carcinomaJ J Lokich, H Bailey, D B Dixon, et al.
Cancer|April 1, 1976
Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastasesD Munjal, P L Chawla, J J Lokich, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188J Lokich, M Auerbach, L Essig, et al.
Cancer|January 1, 1993
Recent advances in the treatment of advanced colorectal cancerN Kemeny, J J Lokich, N Anderson, et al.
American Journal of Clinical Oncology|October 1, 1984
Protracted vinblastine infusion. Phase I-II study in malignant melanoma and other tumorsJ J Lokich, T E Zipoli, J Perri, et al.
American Journal of Clinical Oncology|April 1, 1985
Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancerH Matelski, R Greene, M Huberman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Plasma clearance of carcinoembryonic antigen following hepatic metastatectomyJ Lokich, S Ellenberg, B Gerson, et al.
Cancer|February 19, 1999
The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbineJ J Lokich, N Anderson, M Bern, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy Reports|March 1, 1975
Phase I. evaluation of cyclocytidine (NSC-145668)J J Lokich, P L Chawla, N Jaffe, et al.
American Journal of Surgery|April 1, 1983
Management of malignant ascites with peritoneovenous shuntingR B Reinhold, J J Lokich, J Tomashefski, et al.
Journal of Surgical Oncology|January 1, 1979
Pseudo-chondrosarcoma: solitary osseous metastases from atypical bronchogenic carcinomaJ J Lokich, H Bailey, D B Dixon, et al.
Cancer|April 1, 1976
Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastasesD Munjal, P L Chawla, J J Lokich, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188J Lokich, M Auerbach, L Essig, et al.
Cancer|January 1, 1993
Recent advances in the treatment of advanced colorectal cancerN Kemeny, J J Lokich, N Anderson, et al.
American Journal of Clinical Oncology|October 1, 1984
Protracted vinblastine infusion. Phase I-II study in malignant melanoma and other tumorsJ J Lokich, T E Zipoli, J Perri, et al.
American Journal of Clinical Oncology|April 1, 1985
Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancerH Matelski, R Greene, M Huberman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Plasma clearance of carcinoembryonic antigen following hepatic metastatectomyJ Lokich, S Ellenberg, B Gerson, et al.
Cancer|February 19, 1999
The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbineJ J Lokich, N Anderson, M Bern, et al.
Pageof 16